Edition:
India

Melinta Therapeutics Inc (MLNT.OQ)

MLNT.OQ on NASDAQ Stock Exchange Global Select Market

3.93USD
18 Jul 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$3.93
Open
--
Day's High
--
Day's Low
--
Volume
18
Avg. Vol
455,541
52-wk High
$31.25
52-wk Low
$1.62

About

Melinta Therapeutics, Inc. develops and commercializes novel antibiotics designed to provide therapeutic solutions. The Company’s lead product is Baxdela, an antibiotic approved by the United States food and drug administration (FDA) for use in the treatment of acute bacterial skin and skin structure infections (ABSSSI). The... (more)

Overall

Beta: 1.07
Market Cap(Mil.): $166.71
Shares Outstanding(Mil.): 52.51
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates